ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.515
+0.035 (2.36%)
Apr 29, 2026, 3:27 PM EDT - Market open

ProQR Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
160213273161264570
Upgrade
Market Cap Growth
35.50%-22.19%70.19%-39.20%-53.63%170.61%
Upgrade
Enterprise Value
6210719356187430
Upgrade
Last Close Price
1.482.022.651.983.708.01
Upgrade
PS Ratio
7.9011.0913.5222.0556.74210.75
Upgrade
PB Ratio
2.693.672.983.513.714.43
Upgrade
P/TBV Ratio
2.623.672.983.513.694.40
Upgrade
P/FCF Ratio
---7.21--
Upgrade
P/OCF Ratio
---6.75--
Upgrade
EV/Sales Ratio
3.235.569.557.6340.19158.93
Upgrade
EV/FCF Ratio
---2.49--
Upgrade
Debt / Equity Ratio
0.320.320.190.480.330.53
Upgrade
Debt / FCF Ratio
---0.98--
Upgrade
Net Debt / Equity Ratio
-1.55-1.55-1.49-2.40-1.09-1.12
Upgrade
Net Debt / EBITDA Ratio
1.801.804.472.911.132.25
Upgrade
Net Debt / FCF Ratio
1.421.423.50-4.921.054.80
Upgrade
Asset Turnover
0.120.120.130.040.020.02
Upgrade
Quick Ratio
3.013.013.893.517.246.83
Upgrade
Current Ratio
3.093.093.963.547.366.94
Upgrade
Return on Equity (ROE)
-61.17%-61.17%-42.73%-51.33%-71.37%-71.62%
Upgrade
Return on Assets (ROA)
-19.35%-19.35%-12.45%-14.06%-21.38%-23.20%
Upgrade
Return on Capital Employed (ROCE)
-54.10%-54.10%-23.60%-33.60%-43.30%-31.40%
Upgrade
Earnings Yield
-32.65%-23.28%-10.51%-19.34%-26.05%-12.12%
Upgrade
FCF Yield
-41.46%-29.69%-14.31%13.88%-27.99%-5.29%
Upgrade
Buyback Yield / Dilution
-22.36%-22.36%-6.26%-13.08%-11.62%-28.21%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.